openPR Logo
Press release

Glycomic Therapeutics Market Size, Share Analysis, Trends, Growth And Forecast To 2032

09-21-2023 06:09 AM CET | Health & Medicine

Press release from: The Business research company

Glycomic Therapeutics Global Market

Glycomic Therapeutics Global Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Glycomic Therapeutics Global Market Report 2023 identifies increase in the prevalence of diabetes as the major driver for the Glycomic Therapeutics market's growth in the forecast period. Diabetes is a chronic medical condition that affects the body's ability to regulate blood sugar (glucose) levels. In diabetes, alterations in glycans have been observed, which can contribute to insulin resistance and other metabolic abnormalities. Specific glycan patterns serve as biomarkers for diagnosing diabetes, predicting its progression, and monitoring treatment responses.

The global glycomic therapeutics market size is expected to grow from $121.85 billion in 2022 to $141.31 billion in 2023 at a compound annual growth rate (CAGR) of 16.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of glycomic therapeutics market is expected to reach $255.71 billion in 2027 at a CAGR of 16.0%.

Download Free Sample Of Glycomic Therapeutics Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=11894&type=smp

Major competitors in the Glycomic Therapeutics market are F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation.

A key trend in the Glycomic Therapeutics market includes Product innovation. Major companies operating in the glycomic therapeutics sector are focused on developing new technological and innovative solutions to strengthen their position in the market.

Read More On The Global Glycomic Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report

The Glycomic Therapeutics market is segmented -
1) By Class: Isolated, Synthetic
2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures
3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher's Disease, Mps-1 And IV, Cancer, Alzheimer's Disease, Influenza Type A And B, Other Indications

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Glycomic Therapeutics market.

The Business Research Company's "Global Glycomic Therapeutics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Glycomic Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11894

The Table Of Content For The Glycomic Therapeutics Market Include:
1. Executive Summary
2. Glycomic Therapeutics Market Characteristics
3. Glycomic Therapeutics Market Trends And Strategies
4. Glycomic Therapeutics Market - Macro Economic Scenario
5. Glycomic Therapeutics Market Size And Growth
……
27. Glycomic Therapeutics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Glycomic Therapeutics Market
29. Glycomic Therapeutics Market Future Outlook And Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glycomic Therapeutics Market Size, Share Analysis, Trends, Growth And Forecast To 2032 here

News-ID: 3215994 • Views:

More Releases from The Business research company

Top Players and Competitive Environment in the Carbon Dioxide Recycling Methanol Market
Top Players and Competitive Environment in the Carbon Dioxide Recycling Methanol …
The carbon dioxide recycling methanol market is poised for remarkable expansion as the world intensifies efforts toward sustainability and carbon neutrality. With increasing emphasis on reducing greenhouse gas emissions and boosting renewable energy sources, this market is set to play a pivotal role in the global transition to cleaner fuels and circular carbon economies. Here's a detailed look at its projected growth, influential players, emerging trends, and segmentation. Forecasted Market Growth
Emerging Sub-Segments Transforming the Caprolactam Market Landscape
Emerging Sub-Segments Transforming the Caprolactam Market Landscape
The caprolactam market is set for significant expansion in the coming years, driven by evolving industrial needs and sustainability initiatives. This report delves into the anticipated growth, key players, emerging trends, and detailed market segmentation to offer a comprehensive view of the sector's future trajectory. Caprolactam Market Size Forecast Through 2030 The caprolactam market is projected to reach a value of $24.38 billion by 2030, growing at a compound annual
Emerging Growth Patterns Driving Expansion in the Butyl Acrylate Market
Emerging Growth Patterns Driving Expansion in the Butyl Acrylate Market
The butyl acrylate market is gaining considerable attention as industries increasingly seek versatile chemical compounds to enhance their products. With its broad utility across coatings, adhesives, and textiles, the market is set for significant growth in the coming years. Let's explore the current market size, the main players, key trends, and segment insights shaping this industry. Projected Market Size and Growth in Butyl Acrylate The butyl acrylate market is poised
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Boron Nitride Coatings Market
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Bo …
Boron nitride coatings are gaining increased attention due to their versatile applications and enhanced protective qualities. As industries like automotive, aerospace, and electronics evolve, the demand for advanced coating solutions that can withstand extreme conditions is rising. This overview explores the current market size, key players, important trends, and dominant segments shaping the boron nitride coatings market. Strong Market Growth Expected for Boron Nitride Coatings by 2030 The boron nitride

All 5 Releases


More Releases for Glycomic

Rising Diabetes Prevalence Fuels Growth In The Glycomic Therapeutics Market: A S …
The Glycomic Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Glycomic Therapeutics Market Size and Projected Growth Rate? In recent times, the market size for glycomic therapeutics has experienced swift expansion. It is projected to escalate from $164.71 billion in 2024 to
Primary Catalyst Driving Glycomic Therapeutics Market Evolution in 2025: Rising …
What market dynamics are playing a key role in accelerating the growth of the glycomic therapeutics market? The anticipated rise in diabetes cases is predicted to propel the expansion of the glycomic therapeutics market. Diabetes, a long-lasting health condition, impairs the body's capacity to regulate blood sugar or glucose levels. Notably, changes in glycans have been identified in diabetes, which possibly contribute to insulin resistance and additional metabolic irregularities. Particular patterns
Glycomic Therapeutics Market Analysis till 2028 - Scope of The Report
The global glycomic therapeutics market is expected to grow from US$ 99,021.46 million in 2021 to US$ 257,578.79 million in 2028; it is estimated to grow with a CAGR of 15.8% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth. The demand for glycomic therapeutics is attributed to a wide application of glycan-based drugs followed by the development of new treatment processes, increasing research and
Glycomic Therapeutics Market Insights, Demand, and Forecast to 2033
"The new report published by The Business Research Company, titled Glycomic Therapeutics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the glycomic therapeutics market size has grown rapidly in recent years. It will grow from $141.31 billion in
Glycomic Therapeutics Market: Advancements, Opportunities, and Growth Potential
Market Overview: Glycomic therapeutics involves the development and utilization of glycan-based drugs or therapies to target specific molecular interactions and pathways in the human body. Glycans play critical roles in cell communication, immune responses, and disease progression, making them attractive targets for therapeutic interventions. The market encompasses various applications, including cancer therapeutics, infectious disease therapeutics, and personalized medicine. Market Size and Growth: The Glycomic Therapeutics Market is experiencing significant growth, driven
Glycomic Therapeutics Market Demand, Investment And Forecast 2028
According to Premium Market Insights new research study on "Glycomic Therapeutics Market is expected to grow from US$ 99,021.46 million in 2021 to US$ 257,578.79 million in 2028; it is estimated to grow with a CAGR of 15.8% from 2022 to 2028. Get a Sample Copy of This Report@ https://www.premiummarketinsights.com/sample/TIP00073621/?utm_source=OpenPR&utm_medium=10655 Some Of the Major Players Influencing are Intellihep Ltd, Protalix Biotherapeutics, BioMarin Pharmaceutical Inc., Genzyme Corporation (Sanofi), Halozyme Therapeutics, Inc., Bayer